A Closer Look at 9 Analyst Recommendations For CG Oncology
A Closer Look at 9 Analyst Recommendations For CG Oncology
對CG Oncology進行的九項分析師建議的詳細評估
9 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish.
過去季度，有9位分析師分別對CG Oncology（NASDAQ：CGON）提出了各種觀點，從看好到看淡提供了多樣化的意見。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Analysts have recently evaluated CG Oncology and provided 12-month price targets. The average target is $68.33, accompanied by a high estimate of $75.00 and a low estimate of $50.00. This current average has decreased by 1.92% from the previous average price target of $69.67.
分析師最近對CG Oncology進行了評估，提出了12個月的價格目標。平均目標爲$68.33，高估爲$75.00，低估爲$50.00。這個當前平均值比之前的平均目標價$69.67下降了1.92%。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
In examining recent...
通過審...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。